NOVODX Corporation
NOVODX develops a portable, smartphone-connected at‑home diagnostic platform that combines optics, disposable assay cassettes, and AI-assisted interpretation with HIPAA-compliant cloud storage. The primary device platform (under development) is intended to provide rapid biomarker screenings (~15 minutes), history tracking, and secure data sharing for home, clinic, and field use. The company is based in Jupiter, FL and identifies as women‑owned.
Industries
N/A
Nr. of Employees
small (1-50)
NOVODX Corporation
110 Front Street, Suite 300, Jupiter, FL 33477, USA
Products
GoldN Companion (at-home diagnostic reader)
A portable diagnostic reader under development that analyzes one biomarker per disposable cassette, connects to a smartphone app via Bluetooth, uses AI-assisted interpretation, and stores encrypted data in a HIPAA‑compliant cloud. Not FDA‑cleared and not available for sale at present.
Prenatal nutritional supplement (Omega‑3, Folate, CoQ10 Ubiquinol)
Dietary supplement formulation marketed for prenatal use containing omega-3, folate, CoQ10 and ubiquinol; sold through a separate retail site.
GoldN Companion (at-home diagnostic reader)
A portable diagnostic reader under development that analyzes one biomarker per disposable cassette, connects to a smartphone app via Bluetooth, uses AI-assisted interpretation, and stores encrypted data in a HIPAA‑compliant cloud. Not FDA‑cleared and not available for sale at present.
Prenatal nutritional supplement (Omega‑3, Folate, CoQ10 Ubiquinol)
Dietary supplement formulation marketed for prenatal use containing omega-3, folate, CoQ10 and ubiquinol; sold through a separate retail site.
Services
Customer service for setup and usage support; shipping and order tracking for products.
Subscription-based updates and communications for users tracking product development and release timelines.
Customer service for setup and usage support; shipping and order tracking for products.
Subscription-based updates and communications for users tracking product development and release timelines.
Expertise Areas
- At‑home and point-of-care diagnostics
- Biomarker assay development
- AI-assisted diagnostic interpretation
- Digital health and mobile integration
Key Technologies
- Microfluidics
- Fluorescence-based detection
- Advanced optical sensing
- AI / machine learning for diagnostics
News & Updates
Article discussing applications of big data and AI for infectious disease monitoring.
Discussion of design and deployment considerations for at‑home rapid diagnostics.
Overview of the role of genetic testing in precision medicine.
Article about using connected technologies to improve health accessibility and wellbeing.
Essay on the shift from laboratory diagnostics to continuous, at‑home testing and its implications for prevention and equity.
Article discussing applications of big data and AI for infectious disease monitoring.
Discussion of design and deployment considerations for at‑home rapid diagnostics.
Overview of the role of genetic testing in precision medicine.
Article about using connected technologies to improve health accessibility and wellbeing.
Essay on the shift from laboratory diagnostics to continuous, at‑home testing and its implications for prevention and equity.